GSK-3β inhibitor 2
GSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's disease[1].
Product Specifications
CAS Number
[1702428-31-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gsk-3β-inhibitor-2.html
Purity
97.68
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
O=C(C1=C(OC)N=C(C2=CC(NC(C3CC3)=O)=NC=C2)S1)N
Molecular Formula
C14H14N4O3S
Molecular Weight
318.35
Precautions
H302, H315, H319, H335
References & Citations
[1]Sivaprakasam P, et al. Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core. Bioorg Med Chem Lett. 2015 May 1;25 (9) :1856-63.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
A90-105B 1 mg
Goat anti-Mouse IgGl Heavy Chain Antibody Biotinylated
Sign In for Pricing
View Details 
LV698960 1.0 µg DNA
SLIT1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 
GTR15139863 1 Vial
Lentiviral human HDHD2 shRNA (UAS) - Lentiviral human HDHD2 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 